Dark

PCSA
Processa Pharmaceuticals, Inc. Common
stock NASDAQ

At Close

Mar 11, 2026 3:59:30 PM EDT

2.85USD-2.397%(-0.07)45,366

2.45Bid 3.31Ask 0.86Spread

Pre-market

Mar 6, 2026 8:29:30 AM EST

2.80USD-4.000%(-0.12)0

After-hours

Mar 6, 2026 4:42:30 PM EST

2.65USD-4.332%(-0.12)0

OverviewHistoricalExchangesShortsMore

open chart

Market Cap

6.46M

Industry

Biotechnology

Next Earnings

Mar 19, 2026 (7d)

Last Split

Dec 17, 20251for25reverse

PCSA Stats

Avg. Vol. 10 Day

34,716

Avg. Vol. 30 Day

43,744

Employees

Market Cap

6,457,439

Shares Out.

2,265,768

On/Off Exchange

42%/58%

6 Month Beta

0.73

1 Year Beta

0.38

2 Year Beta

0.49

3 Year Beta

0.62

52 Week Low

1.76

52 Week High

19.63

SMA50

2.80

SMA200

5.47

1 Week

+1.79%

1 Month

+16.33%

3 Month

-58.09%

6 Month

-40.59%

1 Year

-75.10%

2 Year

-95.00%

5 Year

-99.95%

Profile

processa pharmaceuticals was founded in october 2017 with a mission to develop products that can improve the survival and/or quality of life for patients who have a high unmet medical need. the company is headquartered in hanover, maryland.

PCSA Stock Summary

Processa Pharmaceuticals, Inc. Common (NASDAQ:PCSA) stock price today is $2.85, and today's volume is 45,366. PCSA is down -2.397% today. The 30 day average volume is 43,744. PCSA market cap is 6.46M with 2,265,768 shares outstanding.

.dark-mode .gkjLRS{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .gkjLRS{ color: #333333; background-color: white; border: 2px solid #333333; }PCSAProcessa Pharmaceuticals, Inc. Commonstock NASDAQ

PCSA Stock Summary

PCSA
Processa Pharmaceuticals, Inc. Common
stock NASDAQ